Anxiety Disorders Completed Phase 2 Trials for Emapunil (DB12666)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00108836Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety DisorderTreatment